Veradermics, Incorporated MANE
$135.29
-13.59%
at last close
Market Cap$6.61 billion
P/E Ratio—
Div Yield—
Volume2.30M
52-Week Range
$32.00$156.63
Analyst Ratings
- Consensus
- Buy — 7 Buy · 0 Hold · 0 Sell (7 analysts)
- Avg. Price Target
- $169.67 (+25.4% upside)
Key Stats
- Today's Range
- $133.91 – $147.53
- 50-Day Range
- $95.42 – $156.63
- 52-Week Range
- $32.00 – $156.63
- Volume
- 2.30 million shs
- Average Volume
- 822K shs
- Market Cap
- $6.61 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 2.45%
- Days to Cover
- 1.71
About Veradermics, Incorporated
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.
Related Stocks
Compare head-to-head: MANE vs LLY·MANE vs JNJ·MANE vs ABBV·MANE vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.